3C Therapeutics
1 known investors
3C Therapeutics develops a platform for targeted protein degradation to enable intracellular protein degraders and antibody delivery, using its proprietary TriCore technology to eliminate disease-causing proteins for pharmaceutical applications.
BiotechDeep TechMedical Devices